Ocugen market cap OCGN
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Nov 2, 2026
- $245.8M
- Highest close in our data
- $2.4B
- Apr 2021
Ocugen is worth $245.8M at the close on Nov 2, 2026, at $0.72 a share.
That is down 42% over the last year and down 88% over five years.
Its highest close in our data was $2.4B in Apr 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $245.8M | $238.3M | $813.2M | −44% |
| 2025 | $440.4M | $156.9M | $517.4M | +79% |
| 2024 | $246.3M | $131.3M | $491.5M | +67% |
| 2023 | $147.5M | $92.1M | $284.6M | −48% |
| 2022 | $284.6M | $264.9M | $846.5M | −69% |
| 2021 | $906.3M | $286.8M | $2.4B | +206% |
| 2020 | $296.5M | $4.8M | $296.5M | +4532% |
| 2019 | $6.4M | $1.6M | $28.3M | +12% |
| 2018 | $5.7M | $5.7M | $85.2M | −88% |
| 2017 | $49.3M | $24.2M | $50.6M | +85% |
| 2016 | $26.6M | $22M | $48.1M | −43% |
| 2015 | $46.5M | $39M | $110.4M | n/a |
Against its peers
Companies in Biotechnology nearest Ocugen's size, closest first, today.
| Company | Market cap |
|---|---|
| OCGNOcugen | $245.8M |
| PLXProtalix BioTherapeutics | $206.3M |
| MGTXMeiraGTx | $895.1M |
| VCELVericel | $2.1B |
| Peer median | $895.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Ocugen
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.